Table 1.
Baseline characteristics of patients during baseline, intervention or both phases
| Characteristic | Study Phase |
|||||
|---|---|---|---|---|---|---|
| Baseline only | Both phases | Intervention only | ||||
| Number of patients | 2388 | 1173 | 2800 | |||
| Mean age, yrs (SD) | 60.3 | (16.1) | 61.3 | (15.5) | 60.6 | (15.8) |
| Female, n (%) | 910 | (38.1%) | 508 | (43.3%) | 1,085 | (38.8%) |
| Ethnicity, n (%) | ||||||
| Asian | 198 | (8.3%) | 94 | (8.0%) | 228 | (8.1%) |
| First Nationsa | 229 | (9.6%) | 160 | (13.6%) | 348 | (12.4%) |
| Pacific Islander | 58 | (2.4%) | 34 | (2.9%) | 65 | (2.3%) |
| White | 1584 | (66.3%) | 704 | (60.0%) | 1796 | (64.1%) |
| Other or not recorded | 319 | (13.4%) | 181 | (15.4%) | 363 | (13.0%) |
| Diabetes mellitus, n (%) | 973 | (40.7%) | 596 | (50.8%) | 1213 | (43.3%) |
| Immunosuppressed, n (%) | 341 | (14.3%) | 123 | (10.5%) | 383 | (13.7%) |
a
Includes Aboriginal and Torres Strait Islander and Māori.